Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
US6344479 | RECORDATI RARE | Method of preventing retinopathy of prematurity in a neonate |
Mar, 2021
(3 years ago) | |
US8415337 | RECORDATI RARE | Ibuprofen compositions and methods of making same |
Mar, 2032
(7 years from now) | |
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6342530 | RECORDATI RARE | Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt |
Nov, 2020
(3 years ago) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
Orphan Drug Exclusivity(ODE) | Apr 13, 2013 |
Market Authorisation Date: 13 April, 2006
Treatment: Treatment of patent ductus arteriosus; Closure of a clinically significant patent ductus arteriosus in premature infants weighing between 500 and 1500g, who are no more than 32 weeks gestational age w...
Dosage: INJECTABLE;INTRAVENOUS